Answers are grounded in this paper and cite their sources.
Demonstrates that lipophilic 1,1-bisphosphonates inhibit squalene synthase and lower cholesterol in rodents, highlighting a selective alternative that spares coenzyme-Q9.
Squalene synthase catalyzes the reductive dimerization of two molecules of farnesyl diphosphate to form squalene at the final branchpoint of the cholesterol biosynthetic pathway. We report herein that isoprenyl 1,1-bisphosphonates and related analogs are potent inhibitors of rat microsomal squalene synthase (I50 = 0.7-32 nM). In addition, members of this family are potent inhibitors of cholesterol biosynthesis in rats on intravenous and oral dosing, as well as cholesterol lowering agents in rats and hamsters. Significant inhibition of cholesterol biosynthesis in rats by lovastatin occurs with a concomitant inhibition of dolichol and coenzyme-Q9 synthesis. In contrast, bisphosphonate 4 has no effect on dolichol and coenzyme-Q9 biosynthesis in rats under conditions where cholesterol biosynthesis is > 90% inhibited.
No takes yet. Share an insight, caveat, or question.
Ciosek et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: